Functional outcomes among the survivors of veno-venous extracorporeal membrane oxygenation during the COVID-19 pandemic: a historical cohort study
Authors' conclusion
Patients who required VV-ECMO experienced significant functional disability, pain, cognitive challenges, mental health problems, and lower quality of life approximately two years after discharge.
Study context
- Population
- Survivors who required veno-venous extracorporeal membrane oxygenation (VV-ECMO) for respiratory failure during the COVID-19 pandemic22 (85%) COVID-19
- Participants
- 26 survivors
- Outcome
- Postdischarge psychological and functional outcomes (disability: WHODAS 2.0, mRS; quality of life; cognition; depression; PTSD symptoms)
- Follow-up
- Median 22 [IQR 17-23] months after ECMO separation
Methodological detailstelephone interviews, descriptive statistics
- Telephone interviews
- Descriptive statistics
Main finding
As reported in the abstract
Disability (WHODAS 2.0 score) · median 22 [17-23] months after ECMO separation
Median [IQR] WHODAS 2.0 score; highest disability in mobility and participation domains
26
15–30
Observational data: associations, not effects.
Original publication
Functional outcomes among the survivors of veno-venous extracorporeal membrane oxygenation during the COVID-19 pandemic: a historical cohort study. Can J Anaesth. Published 29 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →